| Thyroid function and insulin sensitivity before and after bilio-pancreatic diversion. | |
| | |
MedLine Citation:
|
PMID: 19885706 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Bilio-pancreatic diversion (BPD) induces permanent weight loss in previously severe obese patients through a malabsorptive mechanism. The aim of the study was to evaluate the modifications of circulating thyroid hormones after BPD, a surgical procedure which interferes with the entero-hepatic circulation of biliary metabolites. METHODS: Forty-five patients were studied before and 2 years after BPD. Thyroid-stimulating hormone (TSH), free triiodothyronine (fT3), free thyroxine (fT4), anti-thyroid antibodies, iodine urinary excretion, lipid profile, insulin and glucose plasma levels were assessed. The insulin-resistance HOMA IR index was calculated, and colour Doppler ultrasonography of the neck was performed. RESULTS: The subjects (23%) had subclinical hypothyroidism prior to BPD (TSH levels above the normal range with normal fT3 and fT4 levels). After 2 years 40.42% of the population showed subclinical hypothyroidism, while 6.3% became frankly hypothyroid, all of them with no evidence of auto-immune thyroiditis. Most of the patients, who became sub-clinically hypothyroid only following BPD, had already thyroid alterations at the sonogram (multi-nodular euthyroid goiter and thyroidal cysts) prior to surgery. CONCLUSIONS: BPD increases the prevalence of subclinical or even frank hypothyroidism, without causing a defect in thyroid function itself, through several integrated mechanisms. (1) It induces iodine malabsorption, which is partially compensated by iodine excretion contraction. (2) The entero-hepatic open circulation determines fT3 loss, which induces subclinical or frank hypothyroidism in patients with pre-existing thyroid alterations, interfering also with the weight loss progress. Iodine supplementation should be recommended in those patients reporting thyroid alterations at the sonogram prior to BPD, LT4 therapy should be strictly monitored in patients suffering of subclinical hypopthiroidism and T3 therapy should eventually be considered for patients diagnosed with frank hypothyroidism prior to BPD. |
| | |
Authors:
|
Donatella Gniuli; Laura Leccesi; Caterina Guidone; Amerigo Iaconelli; Chiara Chiellini; Andrea Manto; Marco Castagneto; Giovanni Ghirlanda; Geltrude Mingrone |
Related Documents
:
|
888746 - Thyroid function tests in the elderly in the community. 405836 - Intravenous and peroral trh stimulation in sporadic atoxic goitre. 171946 - Joint effusions, chondrocalcinosis and other rheumatic manifestations in hypothyroidism... 17630916 - Use of radiopharmaceuticals for diagnosis, treatment, and follow-up of differentiated t... 12910436 - Nox (nitrite/nitrate) in cerebral spinal fluids obtained from patients with influenza-a... 8032046 - Circulating markers of free radical activity in patients with pulmonary tuberculosis. |
Publication Detail:
|
Type: Journal Article Date: 2009-11-03 |
Journal Detail:
|
Title: Obesity surgery Volume: 20 ISSN: 1708-0428 ISO Abbreviation: Obes Surg Publication Date: 2010 Jan |
Date Detail:
|
Created Date: 2010-01-21 Completed Date: 2010-04-13 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9106714 Medline TA: Obes Surg Country: United States |
Other Details:
|
Languages: eng Pagination: 61-8 Citation Subset: IM |
Affiliation:
|
Department of Internal Medicine and Diabetes Center, Catholic University, L.go Gemelli 8, 00168 Rome, Italy. dgniuli@gmail.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Biliopancreatic Diversion* Body Composition Female Humans Hypothyroidism / etiology, physiopathology Insulin Resistance / physiology* Liver Circulation / physiology Male Middle Aged Obesity, Morbid / physiopathology*, surgery* Postoperative Period Thyroid Gland / physiopathology*, ultrasonography Thyrotropin / blood Thyroxine / blood Triiodothyronine / blood Ultrasonography, Doppler, Color |
| Chemical | |
Reg. No./Substance:
|
6893-02-3/Triiodothyronine; 7488-70-2/Thyroxine; 9002-71-5/Thyrotropin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The METER: a brief, self-administered measure of health literacy.
Next Document: Metabolic/Bariatric Surgery Worldwide 2008.